日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Boosting CAR T-cell efficacy by blocking proteasomal degradation of membrane antigens

通过阻断膜抗原的蛋白酶体降解来提高CAR T细胞的疗效

Rieger, Leonie; Irlinger, Kilian; Füchsl, Franziska; Tietje, Marlene; Purcarea, Anna; Barbian, Nicolas; Faber, Melanie; Vogelsang, Carolin; Pfeuffer, Lisa; Stotz, Sonja; Karpiuk, Oleksandra; Schulze, Tobias; Augsburger, Abirami; Glaisner, Nadine; Konetzki, Verena; Friedel, Sabrina; Besse, Andrej; Besse, Lenka; Driessen, Christoph; Buchner, Maike; Schwamborn, Kristina; Steiger, Katja; Giansanti, Piero; Theurich, Sebastian; Waldschmidt, Johannes; Kortüm, K Martin; Hudecek, Michael; Einsele, Hermann; Högner, Marion; Kuster, Bernhard; Krackhardt, Angela M; Hecker, Judith S; Bassermann, Florian

Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination

通过亲和力组合平衡嵌合抗原受体T细胞疗法的疗效和安全性

Warmuth, Linda; Dötsch, Sarah; Trebo, Manuel; Bellucci, Sarah; Engels, Sophia; Valdivia Manrique, Rafael; Moukarzel, Karl; Schütz, Julius M; Hammel, Monika; Straub, Adrian; Wagner, Sabrina; Hochholzer, Anna; Salinno, Ciro; Seigner, Jacqueline; Zajc, Charlotte U; Schmidt, Georg P; Michael, Josefine; Nerreter, Thomas; Hudecek, Michael; Traxlmayr, Michael W; Casucci, Monica; Riddell, Stanley R; Poltorak, Mateusz P; Busch, Dirk H; D'Ippolito, Elvira

The European CAR-T map-Current status and future directions to improve access to CAR T-cell therapy for hematologic malignancies

欧洲CAR-T细胞疗法图谱——改善血液系统恶性肿瘤CAR-T细胞疗法可及性的现状与未来方向

Pennings, Elise R A; Thielen, Frederick W; Broussais, Florence; Delgado, Julio; Jaeger, Ulrich; Sanges, Carmen; Cabrerizo, Yolanda; Roux-Opstaele, Lutgart; Dreuillet, Caroline; Gonzalez-Marcano, Eglys; Millán, Olga; Huber, Barbara; Clavreul, Solène; Bolaños, Natacha; Nier, Samantha; Mihályová, Jana; Hájek, Roman; Horňáková, Michaela; Doeswijk, Robin; Thieblemont, Catherine; Hudecek, Michael; Uyl-de Groot, Carin A; Kersten, Marie José

Co-expression of an adapter CAR retains efficacy of CAR T cells after single and dual antigen loss in lymphoma

在淋巴瘤中,即使发生单抗原或双抗原丢失,接头CAR的共表达仍能保持CAR T细胞的疗效。

Riester, Zeno; Surowka, Marlena; Seifert, Nicole; Darowski, Diana; Ghosh, Arindam; Spieler, Peter; Weber, Justus; Gianotti, Reto; Freitag, Fabian; Alb, Miriam; Nerreter, Thomas; Gerhard-Hartmann, Elena; Rosenwald, Andreas; Sauer, Markus; Moessner, Ekkehard; Einsele, Hermann; Ferrara-Koller, Claudia; Klein, Christian; Hudecek, Michael; Danhof, Sophia

The uneven landscape of Swiss travel behavior: evidence of mobility inequality from the national microcensus

瑞士旅行行为格局的不均衡:来自国家微观普查的流动性不平等证据

Hudecek, Matthias F C; Kammer, Julia K; Moser, Corinne

Design specifications for biomedical virtual twins in engineered adoptive cellular immunotherapies

生物医学虚拟孪生体在工程化过继细胞免疫疗法中的设计规范

Weirauch, Ulrike; Kreuz, Markus; Birkenbihl, Colin; Alb, Miriam; Quaranta, Maria; Calzone, Laurence; Orozco-Ruiz, Sophia; Binder, Stefanie; Fischer, Luise; Clavreul, Solène; Maguri, Morine; Ferle, Maximilian; Rade, Michael; Azarias, Guillaume; Hydren, Jay R; Jamarik, Jakub; Schwarz, Daniel; Sebestyen, Zsolt; Kuball, Jurgen; Popp, Georg; Antoine, Chloé; Knockaert, Manon; Schoeder, Clara T; Fandrei, David; Sanges, Carmen; Radvilas, Vaclovas; Gagelmann, Nico; Rückert, Markus; Penack, Olaf; Fricke, Stephan; Schmidt, Andreas; Ward, Carol; Steinbeisser, Carl; Van Gyseghem, Jean-Marc; Niarakis, Anna; Garderet, Laurent; Hudecek, Michael; Neumuth, Thomas; Platzbecker, Uwe; Köhl, Ulrike; Demlova, Regina; Kremer, Andreas; Franke, Stefan; Fröhlich, Holger; Merz, Maximilian; Reiche, Kristin

Endothelial dysfunction and proinflammatory state determine severe hematotoxicity and inferior outcome of CAR-T therapy

内皮功能障碍和促炎状态决定了CAR-T疗法的严重血液毒性和不良疗效。

Scheller, Lukas; Zhou, Xiang; Loeffler-Wirth, Henry; Kreuz, Markus; Kadel, Sofie-Katrin; Schimanski, Sven; Schulze, Hannah; Ruckdeschel, Anna; Eisele, Florian; Konetzki, Verena; Jornet Culubret, Maria; Merz, Maximilian; Mersi, Julia; Waldschmidt, Johannes; Danhof, Sophia; Köhl, Ulrike; Kortüm, K Martin; Rasche, Leo; Einsele, Hermann; Düll, Johannes; Topp, Max S; Hudecek, Michael; Reiche, Kristin; Alb, Miriam

Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary resistance to anti-BCMA immunotherapy in multiple myeloma.

血浆置换可促进可溶性 BCMA 的清除,并有助于逆转多发性骨髓瘤对 BCMA 抗免疫疗法的原发性耐药性。

Neubert Sven, Munawar Umair, Mersi Julia, Noderer Julia, Nerreter Silvia, Kurian Shilpa, Han Seungbin, Verbruggen Christina, Besant Emma, Rein Nina, Köppel Max, Lehmann Johanna, Köhler Tabea, Labinsky Hannah, Häusl Sigrun, Tamamushi Yoko, Zhou Xiang, Pinter Jule, Herzog Anna Laura, Lopau Kai, Hoxha Elion, Rummelt Christoph, Gerhard-Hartmann Elena, Rosenwald Andreas, Steinbrunn Torsten, Nerreter Thomas, Hudecek Michael, Einsele Hermann, Rasche Leo, Kortüm K Martin, Waldschmidt Johannes M

Depletion of alloreactive B cells by drug-resistant chimeric alloantigen receptor T cells to prevent transplant rejection

利用耐药嵌合型同种异体抗原受体T细胞清除同种异体反应性B细胞,以防止移植排斥反应

Dragon, Anna Christina; Bonifacius, Agnes; Lienenklaus, Stefan; Verboom, Murielle; Gerhards, Jan-Phillipp; Ius, Fabio; Hinze, Christian; Hudecek, Michael; Figueiredo, Constanca; Blasczyk, Rainer; Eiz-Vesper, Britta

Optimizing CAR-T treatment: A T(2)EVOLVE guide to raw and starting material selection

优化 CAR-T 治疗:AT(2)EVOLVE 原料和起始材料选择指南

Navarro, Sergio; Moukheiber, Carole; Inogés Sancho, Susana; Ruiz Guillén, Marta; López-Díaz de Cerio, Ascensión; Sanges, Carmen; Tanaka, Toshimitsu; Arnould, Sylvain; Briones, Javier; Dolstra, Harry; Hudecek, Michael; Choudhary, Rashmi; Schapitz, Inga; Juan, Manel; Worel, Nina; Ammar, Delphine; Luu, Maik; Müller, Mirko; Schroeder, Bernd; Negre, Hélène; Franz, Paul